Immucell Corp (ICCC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,573 | 850 | 2,270 | 2,674 | 782 |
| Marketable Securities | 4,471 | 2,489 | 2,985 | 2,240 | 4,178 |
| Receivables | 718 | 1,005 | 631 | 611 | 384 |
| Inventories | 870 | 946 | 1,207 | 1,649 | 1,667 |
| Income taxes - deferred | N/A | 31 | 15 | 31 | 59 |
| TOTAL | $7,880 | $5,469 | $7,268 | $7,363 | $7,151 |
| Non-Current Assets | |||||
| PPE Net | 5,719 | 3,838 | 2,525 | 2,358 | 2,515 |
| Investments And Advances | 490 | 496 | 0 | 0 | 0 |
| Other Non-Current Assets | 452 | 1,249 | 1,168 | 1,310 | 1,325 |
| TOTAL | $6,661 | $5,583 | $3,693 | $3,667 | $3,841 |
| Total Assets | $14,540 | $11,052 | $10,961 | $11,030 | $10,991 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 131 | 150 | 190 | 182 | 173 |
| Accounts payable and accrued liabilities | 662 | 852 | 445 | 229 | 150 |
| Accrued Expenses | N/A | N/A | N/A | 256 | 304 |
| TOTAL | $793 | $1,009 | $636 | $666 | $635 |
| Non-Current Liabilities | |||||
| Long Term Debt | 3,055 | 746 | 896 | 1,087 | 1,268 |
| Deferred Revenues | 0 | 7 | 0 | N/A | 8 |
| Other Non-Current Liabilities | 79 | 39 | 33 | 83 | 68 |
| TOTAL | $3,134 | $785 | $929 | $1,170 | $1,336 |
| Total Liabilities | $3,926 | $1,794 | $1,565 | $1,836 | $1,971 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 4,179 | 3,028 | 3,027 | 3,019 | N/A |
| Common Shares | 326 | 326 | 326 | 326 | 326 |
| Retained earnings | 639 | -575 | -407 | -525 | -614 |
| Other shareholders' equity | -501 | 465 | 466 | 420 | 397 |
| TOTAL | $10,614 | $9,258 | $9,396 | $9,195 | $9,020 |
| Total Liabilities And Equity | $14,540 | $11,052 | $10,961 | $11,030 | $10,991 |